Chemical Properties:
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer with High Purity and Stable Quality Chemical Name: Etravirine (TMC-125) CAS: 269055-15-4 API High Quality, Commercial Production| Item | Specifications |
| Appearance | White Solid Powder |
| Identification | By IR, HPLC |
| Melting Point | 211.0~216.0℃ |
| Water Content | ≤0.50% |
| Residue on Ignition | ≤0.20% |
| Heavy Metals | ≤20ppm |
| Any Single Impurity | ≤0.50% |
| Total Impurities | ≤1.0% |
| Assay | ≥99.0% (HPLC) |
| Test Standard | Enterprise Standard |
Description:
Specifications:
Package & Storage:
| Chemical Name | Etravirine |
| Synonyms | TMC-125 |
| CAS Number | 269055-15-4 |
| CAT Number | RF-API54 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C20H15BrN6O |
| Molecular Weight | 435.28 |
| Density | 1.439 g/cm3 |
| Shipping Condition | Under Ambient Temperature |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Etravirine (TMC-125) (CAS 269055-15-4) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. It is indicated for use in combination with other antiretroviral agents for treating HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to the currently available NNRTIs and other antiretroviral agents. The NNRTIs, along with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), are important components of the combination regimens currently used to treat HIV-1 infection. The NRTIs/NtRTIs act by competing with the natural nucleotide substrates of reverse transcriptase for incorporation into viral DNA and subsequent chain termination. By contrast, the NNRTIs bind to an allosteric site of the enzyme and disrupt the DNA polymerase function by inducing conformational changes to the catalytic site.
